On paper great. - Recensione dipendente - Bioinformatics Scientist presso NeoGenomics

3,0
5 set 2024
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Lots of benefits like pension, health insurance, life insurance, enhanced maternity leave, and decent pay.

Svantaggi

R&D department focus is messy, and always changing, reducing the sense of stability and making it difficult to plan a career growth.

Esplora altre recensioni su NeoGenomics

5,0
11 mar 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Growing business opportunities for many job seekers

Svantaggi

Ever changing approach on direction on projects

2,0
2 mar 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

The workforce wants to do the right thing. We take pride in knowing our services impact people's lives everyday.

Svantaggi

Constant turnover, lack of communication throughout - top to bottom. Leadership is struggling and not performing, Most of their attempts to improve growth have lost money. This is factual, not to be mistaken with statements from a disgruntled employee. An article published after the recent earnings release emphasized NEO's 5-year Return on Invested Capital is -10.5%, meaning management doesn't spend our capital wisely. This, along with heavy debt, minimal cash and returns at the bottom of the healthcare sector, should make you pause and do more research before jumping on board.

5
Vedi recensioni per: Utile|Valutazione|Data|Tutto